APA

Blum K., Chen T. J. H., Bailey J., Bowirrat A., Femino J., Chen A. L. C., Simpatico T., Morse S., Giordano J., Damle U., Kerner M., Braverman E. R., Fornari F., Downs B. W., Rector C., Barh D. & Oscar-Berman M. (20120605). Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?. : Molecular neurobiology.

Chicago

Blum Kenneth, Chen Thomas J H, Bailey John, Bowirrat Abdalla, Femino John, Chen Amanda L C, Simpatico Thomas, Morse Siobhan, Giordano John, Damle Uma, Kerner Mallory, Braverman Eric R, Fornari Frank, Downs B William, Rector Cynthia, Barh Debmayla and Oscar-Berman Marlene. 20120605. Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?. : Molecular neurobiology.

Harvard

Blum K., Chen T. J. H., Bailey J., Bowirrat A., Femino J., Chen A. L. C., Simpatico T., Morse S., Giordano J., Damle U., Kerner M., Braverman E. R., Fornari F., Downs B. W., Rector C., Barh D. and Oscar-Berman M. (20120605). Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?. : Molecular neurobiology.

MLA

Blum Kenneth, Chen Thomas J H, Bailey John, Bowirrat Abdalla, Femino John, Chen Amanda L C, Simpatico Thomas, Morse Siobhan, Giordano John, Damle Uma, Kerner Mallory, Braverman Eric R, Fornari Frank, Downs B William, Rector Cynthia, Barh Debmayla and Oscar-Berman Marlene. Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?. : Molecular neurobiology. 20120605.